spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Netherlands pushes for more generic drug imports from India

The Netherlands is aiming to increase imports of Indian generic drugs into the country, as it looks to diversify its portfolio and avoid supply constraints, Dutch government officials and industry experts said at an event on Friday.

India, popularly referred to as the ‘pharmacy of the world, exported $616 million worth of drugs in fiscal year 2025 to the Netherlands, making it India’s seventh largest export market.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
The biggest market for India is the U.S., where tariff concerns linger. India mostly exports generic drugs that are cheaper versions of popular innovative drugs.

“The Netherlands has a generic uptake of 80% for annual prescriptions… Four out of 5 medicines going to patients are generic drugs,” Kayleigh van Winssen, deputy director of pharmaceutical affairs at the Netherlands ministry of health, said at the International Pharmaceutical Exhibition in New Delhi.

There are over 22,000 medicines authorized for use in the Netherlands, she noted.
The European nation encouraged Indian drug manufacturers to increase exports to the Netherlands and across therapy areas.
The Netherlands delegation said at the event that the country is looking to diversify its portfolio and reduce dependence on single drug suppliers or those with extremely high market share.

There has been a 50% drop in generic medicine registrations in the last five years, with fewer generic products in the market, according to Leon Tinke, managing director of BENU, one of the largest pharmacy chains in the Netherlands.

Under an existing agreement between India and the Netherlands, the countries have been collaborating to train inspectors to learn about the regulatory process.

“Indian inspectors (are) being trained in the Netherlands from both the national and state level…We already had a training in January and other trainings are being lined up,” said Winssen.

“We are also thinking about how we can provide companies with better information,” she said.

Hot this week

J&J’s experimental psoriasis drug shows promise against Bristol’s treatment

Johnson & Johnson said on Wednesday its experimental psoriasis...

Lilly trial shows weight loss with experimental pill flattens over time

Eli Lilly’s Nexperimental GLP-1 pill helped people lose about...

SPIMACO secures $53.3mln financing from Saudi National Bank

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) has...

US weighs Trump-branded website to help shop for cheaper drugs, Bloomberg News reports

U.S. officials are considering a website, possibly named after...

Lilly’s GLP-1 Pill Beats Older Novo Diabetes Drug in Head-to-Head Trial

Patients on Eli Lilly & Co.’s experimental diabetes pill...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img